分析
医薬品市場、サプライチェーン、技術、規制の詳細分析
分析
2026年9月22日•1分で読めます
Pharma Companies Unveil Combined Dyslipidemia, Hypertension and Diabetes Therapies at Korean Lipid Congress
Domestic and foreign pharma firms showcased new combination drugs targeting dyslipidemia alongside hypertension and diabetes at the 15th Korean Society of Lipid and Atherosclerosis International Congress.
分析
2026年9月22日•1分で読めます
Celltrion's OmliClon Biosimilar Gains Strong Market Share in Europe
Celltrion's omalizumab biosimilar OmliClon expands to 26 European countries, achieving over 90% market share in Spain and exceeding sales targets in Italy.
分析
2026年9月21日•1分で読めます
Sandoz Unveils Bio100 Strategy to Expand Biosimilar Portfolio to 100+ by 2040
Sandoz aims to grow its biosimilar lineup from 13 to over 100 products by 2040, boosting post‑patent‑cliff revenue share to 80% and targeting a double in net sales by the mid‑2030s.
分析
2026年9月21日•1分で読めます
US Women's Care Market Sees Rise in Clean‑Ingredient Products, Good Clean Love Leads
US consumers are increasingly seeking clean‑ingredient women’s health products; Good Clean Love’s Almost Naked lubricant tops sales.
分析
2026年9月21日•1分で読めます
Pfizer’s Oral JAK Inhibitor Tofacitinib Approved as First‑Line Therapy for Ankylosing Spondylitis in Korea
Young patients with ankylosing spondylitis are seeing a shift from injectable biologics to Pfizer’s oral JAK inhibitor, tofacitinib, now covered as first‑line treatment.
分析
2026年9月21日•1分で読めます
BaroPharm Submits Securities Filing, Begins KOSDAQ IPO Process
BaroPharm filed a securities report with the Financial Services Commission and announced a public offering of 1.78 million shares, targeting a 16,400‑22,200 KRW price range, aiming for a KOSDAQ listing this year.
分析
2026年9月20日•1分で読めます
Hanmi Science Switches Pharmacy Health Drink Packaging from Cans to Bottles, Launches Sep Nationwide
Hanmi Science will replace the cans of its pharmacy‑only health drink ‘Premium Recipe’ line with 120 mL bottles, rolling out the new packaging to Korean pharmacies from September.
分析
2026年9月20日•1分で読めます
Korea Pfizer partners with Il Dong Pharma to distribute Nutex migraine oral tablet
Korea Pfizer and Il Dong Pharmaceutical have signed a distribution and joint promotion agreement for the migraine drug Nutex oral disintegrating tablet, leveraging Il Dong's CNS sales expertise to accelerate market entry.
分析
2026年9月20日•1分で読めます
CareCamp posts record H1 sales of 7.29 trillion KRW, profit up 29%
GeoYoung Group’s GPO subsidiary CareCamp reported first‑half sales of 7.292 trillion KRW, a 15.9% YoY increase, and operating profit of 1.28 trillion KRW, up 29.1%.
分析
2026年9月20日•1分で読めます
CAR‑T therapy Carvykti sees 50% Q2 sales rise amid scaling challenges
Carvykti, approved in 2022, posted $657 M Q2 net sales, up 50% YoY, but expanding its patient‑specific manufacturing remains a key hurdle.
分析
2026年9月19日•1分で読めます
Pharmacy Inventory Management Critical for Profitability and Cash Flow
Effective control of drug stock, including expiry dates and storage conditions, impacts pharmacy revenue, cash flow, and tax burden.
分析
2026年9月19日•1分で読めます
Korean Pharmacy Names Shift Toward Numeric and Scale‑Based Branding
Analysis of 25,862 operating pharmacies shows a move from friendly names like 'Health' to business‑focused names such as '365' and 'Mega'.